eTelecare Global Solutions Inc., a Philippines-based business process outsourcing company, priced 5.5 million American depository shares at $13.50 per share ($12.50-$14.50 range), for an IPO take of approximately $74.3 million. It will trade on the Nasdaq under ticker symbol ETL, whileMorgan Stanley served as lead underwriter. Shareholders include Electra Partners Mauritius, AIG Asian Opportunity Fund […]
Goldman Sachs is planning to raise between $19 billion and $20 billion for its next buyout fund, according to comments made today by CEO Lloyd Blankfein during the company's annual meeting in New York. www.gs.com
Digital Fuel Technologies Inc., a San Mateo, Calif.-based provider of SLA and service-cost management solutions, has raised $5 million in Series CC funding, according to a regulatory filing. The company had previously raised $35 million since 2000, including a $20 million Series D round in early 2005. Listed shareholders include Apax Partners, Benchmark Capital, Israel […]
Best Buy Co. Inc. (NYSE: BBY) has agreed to acquire Speakeasy Inc., a Seattle-based provider of broadband voice, data and IT services. The deal is valued at approximately $97 million, which is around 1.2x Speakeasy's 2006 revenue of $80 million. Speakeasy has raised around $55 million in VC funding since 2000, from firms like Granite […]
Dr. Sanuj Ravindran has joined Radius Ventures as a principal. He previously was with Burrill & Co., where he worked on such deals as diaDexus, Proventys, Endocyte, Neosil, Cardiokine and Arete. www.radiusventures.com
J. Michael O'Brien has joined Investcorp Real Estate Group as a principal and head of the firm's East Coast real estate asset management activities. He previously was a director with ING Clarion. www.investcorp.com
Regado Biosciences Inc., a Durham, N.C.-based drug company focused on antidote-controlled antithrombotics, has raised $23 million in Series C funding. Caxton Advantage Life Sciences Fund was joined by return backers Domain Associates, Quaker BioVentures and the Aurora Funds. The company previously had raised around $21 million since its 2001 inception. www.regadobiosciences.com
Axial Biotech, a Salt Lake City-based developer of DNA-based pre-symptomatic and prognostic tests for common spinal disorders, has raised $15.3 million in Series B funding. Johnson & Johnson Development Corp. led the deal, and was joined by return backers vSpring Capital and Ohio Biotech Group. www.axialbiotech.com
Thin Battery Technologies Inc., a Cleveland-based producer of thin, flexible, printed power source solutions, has raised $6.2 million in Series A funding. SunBridge Partners led the deal, and was joined by Key Capital Corp., Orix Capital and return backer Early Stage Partners. www.thinbattery.com
LGT Capital Partners, a Swiss alternative investment manager, has made the following hires: Andrew Kwee has joined the firm in New York to lead its U.S. private equity office. He previously spent ten years at GIC Special Investments, where he was responsible for establishing and managing its New York office; Doug Coulter has joined the […]